At the 2022 Plant Protection Symposium, Darren Flynn of the UK’s Health and Safety Executive (HSE) presented an overview of the registration of PPPs in GB.
Darren provided an overview of the structure of the key players in PPP Regulation in GB, the interplay between the HSE, the Chemicals Regulation Division (CRD), Defra and other devolved administrations (such as Northern Ireland), and how they work across a range of disciplines and professions.
One of the main strategic objectives of the CRD is to engage and influence the global chemicals regulatory regime, with the aim of increasing participation in the laying out of these legislations. The CRD has already hosted a session on international approaches to active substance renewals and is arranging another on sharing lessons on transformational activities.
Darren outlined the new active substance process for PPP Regulation in GB, which is similar to the EU process given that it was adopted from the EU PPP Regulation (EC) No. 1107/2009. The GB process is now established, with pre-submission meetings ongoing and strongly encouraged. The active substance review programme has also been established, with applications for renewal and supplementary information submitted according to the timelines set out in the regulation. While this work has proven more complex than originally anticipated, Darren summarised the key requirements for the new renewal process as being: predictability, business planning and a realistic and achievable programme.
Darren provided details on the estimated timelines for admissibility checks, evaluation and overall approval/authorisation times in his presentation.
Darren indicated that GB maximum residue levels (MRLs) are outlined in the GB MRL statutory register, which is available on the HSE website. A formal MRL review programme is planned, prior to which current MRLs will be reviewed as required.
The slides from the PPP Symposium can be purchased at the following link: https://kerona.ie/product/dublin-biocides-symposium-2021-speakers-presentations/
Kerona has been supporting clients authorising PPPs in the EU and UK since their founding in 2014. In order to best support their clients in GB going forward, Kerona now has a GB office. Please contact Kerona Scientific (UK) Ltd for regulatory support and authorisations in GB and Northern Ireland at email@example.com